Annual CFI
$122.42 M
-$61.62 M-33.48%
December 31, 2024
Summary
- As of March 13, 2025, LYEL annual cash flow from investing activities is $122.42 million, with the most recent change of -$61.62 million (-33.48%) on December 31, 2024.
- During the last 3 years, LYEL annual CFI has risen by +$244.00 million (+200.70%).
- LYEL annual CFI is now -33.48% below its all-time high of $184.05 million, reached on December 31, 2023.
Performance
LYEL Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$53.51 M
+$51.59 M+2689.62%
December 31, 2024
Summary
- As of March 13, 2025, LYEL quarterly cash flow from investing activities is $53.51 million, with the most recent change of +$51.59 million (+2689.62%) on December 31, 2024.
- Over the past year, LYEL quarterly CFI has increased by +$154.19 million (+153.14%).
- LYEL quarterly CFI is now -65.01% below its all-time high of $152.91 million, reached on June 30, 2023.
Performance
LYEL Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$122.42 M
+$154.19 M+485.33%
December 31, 2024
Summary
- As of March 13, 2025, LYEL TTM cash flow from investing activities is $122.42 million, with the most recent change of +$154.19 million (+485.33%) on December 31, 2024.
- Over the past year, LYEL TTM CFI has dropped by -$61.62 million (-33.48%).
- LYEL TTM CFI is now -63.06% below its all-time high of $331.39 million, reached on September 30, 2023.
Performance
LYEL TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
LYEL Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -33.5% | +153.1% | -33.5% |
| 3 y3 years | +200.7% | +172.4% | +200.7% |
| 5 y5 years | +129.0% | +235.5% | +208.8% |
LYEL Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -33.5% | +200.7% | -65.0% | +153.1% | -63.1% | +143.1% |
| 5 y | 5-year | -33.5% | +129.0% | -65.0% | +136.9% | -63.1% | +140.0% |
| alltime | all time | -33.5% | +129.0% | -65.0% | +136.9% | -63.1% | +140.0% |
Lyell Immunopharma Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $122.42 M(-33.5%) | $53.51 M(+2689.6%) | $122.42 M(-485.3%) |
| Sep 2024 | - | $1.92 M(-95.7%) | -$31.77 M(-148.2%) |
| Jun 2024 | - | $45.01 M(+104.6%) | $65.98 M(-62.1%) |
| Mar 2024 | - | $21.99 M(-121.8%) | $173.89 M(-5.5%) |
| Dec 2023 | $184.05 M(-1694.9%) | -$100.69 M(-201.0%) | $184.05 M(-44.5%) |
| Sep 2023 | - | $99.67 M(-34.8%) | $331.39 M(+89.8%) |
| Jun 2023 | - | $152.91 M(+375.6%) | $174.63 M(+273.6%) |
| Mar 2023 | - | $32.15 M(-31.1%) | $46.74 M(-505.0%) |
| Dec 2022 | -$11.54 M | $46.65 M(-181.7%) | -$11.54 M(-91.3%) |
| Sep 2022 | - | -$57.09 M(-328.2%) | -$132.05 M(-39.9%) |
| Jun 2022 | - | $25.02 M(-195.8%) | -$219.88 M(-22.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$26.12 M(-64.6%) | -$284.37 M(+133.9%) |
| Dec 2021 | -$121.57 M(-55.6%) | -$73.86 M(-49.0%) | -$121.57 M(+693.4%) |
| Sep 2021 | - | -$144.91 M(+267.1%) | -$15.32 M(-138.7%) |
| Jun 2021 | - | -$39.47 M(-128.9%) | $39.65 M(-291.0%) |
| Mar 2021 | - | $136.68 M(+322.0%) | -$20.76 M(-92.4%) |
| Dec 2020 | -$273.52 M(-35.3%) | - | - |
| Dec 2020 | - | $32.39 M(-136.0%) | -$273.52 M(-10.6%) |
| Sep 2020 | - | -$89.94 M(-9.9%) | -$305.90 M(+41.6%) |
| Jun 2020 | - | -$99.88 M(-14.0%) | -$215.96 M(+86.0%) |
| Mar 2020 | - | -$116.08 M | -$116.08 M |
| Dec 2019 | -$422.43 M | - | - |
FAQ
- What is Lyell Immunopharma annual cash flow from investing activities?
- What is the all time high annual CFI for Lyell Immunopharma?
- What is Lyell Immunopharma annual CFI year-on-year change?
- What is Lyell Immunopharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Lyell Immunopharma?
- What is Lyell Immunopharma quarterly CFI year-on-year change?
- What is Lyell Immunopharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for Lyell Immunopharma?
- What is Lyell Immunopharma TTM CFI year-on-year change?
What is Lyell Immunopharma annual cash flow from investing activities?
The current annual CFI of LYEL is $122.42 M
What is the all time high annual CFI for Lyell Immunopharma?
Lyell Immunopharma all-time high annual cash flow from investing activities is $184.05 M
What is Lyell Immunopharma annual CFI year-on-year change?
Over the past year, LYEL annual cash flow from investing activities has changed by -$61.62 M (-33.48%)
What is Lyell Immunopharma quarterly cash flow from investing activities?
The current quarterly CFI of LYEL is $53.51 M
What is the all time high quarterly CFI for Lyell Immunopharma?
Lyell Immunopharma all-time high quarterly cash flow from investing activities is $152.91 M
What is Lyell Immunopharma quarterly CFI year-on-year change?
Over the past year, LYEL quarterly cash flow from investing activities has changed by +$154.19 M (+153.14%)
What is Lyell Immunopharma TTM cash flow from investing activities?
The current TTM CFI of LYEL is $122.42 M
What is the all time high TTM CFI for Lyell Immunopharma?
Lyell Immunopharma all-time high TTM cash flow from investing activities is $331.39 M
What is Lyell Immunopharma TTM CFI year-on-year change?
Over the past year, LYEL TTM cash flow from investing activities has changed by -$61.62 M (-33.48%)